[Federal Register Volume 78, Number 138 (Thursday, July 18, 2013)]
[Notices]
[Page 42969]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-17188]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Muscular Dystrophy Coordinating Committee (MDCC).
    The meeting will be open to the public and accessible by live 
webcast.

    Name of Committee: Muscular Dystrophy Coordinating Committee.
    Type of Meeting: Open Meeting.
    Date: August 26, 2013.
    Time: 8:30 a.m. to 4:30 p.m. *Eastern Time*--Approximate end 
time.
    Agenda: The purpose of this meeting is to bring together the 
committee members to update one another on individual agency 
efforts, to discuss planning for revision of the Action Plan for the 
Muscular Dystrophies, and to discuss two issues affecting all types 
of muscular dystrophy: (a) Transitions to adulthood, career, and 
independence for individuals with muscular dystrophy and (b) 
therapeutic misconception in clinical trials.
    An agenda is posted to the MDCC Web site: http://www.ninds.nih.gov/find_people/groups/mdcc/index.htm.
    Registration: To register, please go to: https://meetings.ninds.nih.gov/meetings/2013_MDCC_Meeting/.
    Webcast Live: For those not able to attend in person, this 
meeting will be webcast at: http://videocast.nih.gov/.
    Place: Neuroscience Center, 6001 Executive Boulevard, Conference 
Room A1/A2, Rockville, Maryland 20852-1699.
    Contact Person: John D. Porter, Ph.D., Executive Secretary, 
Muscular Dystrophy Coordinating Committee, National Institute of 
Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard, 
NSC 2172, Bethesda, MD 20892, (301) 496-5739, 
[email protected].

    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Only one representative of an 
organization may be allowed to present oral comments and if accepted 
by the committee, presentations may be limited to five minutes. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee by forwarding their statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Attendance is limited to seating space available. Individuals 
who plan to attend and need special assistance, such as sign 
language interpretation or other reasonable accommodations, should 
inform the Contact Person listed below in advance of the meeting.
    All visitors must go through a security check at the Lobby of 
the Neuroscience Center (NSC) building to receive a visitor's badge. 
A government issued photo ID is required.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: July 11, 2013.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-17188 Filed 7-17-13; 8:45 am]
BILLING CODE 4140-01-P